Literature DB >> 32096046

Tau Prion-Like Propagation: State of the Art and Current Challenges.

Simon Dujardin1, Bradley T Hyman2.   

Abstract

It has been almost a decade since the hypothesis of active tau protein propagation in Alzheimer's disease and associated tauopathies was formally raised. We view tau propagation as a cascade of events, starting with early tau misfolding, followed by transfer to another, anatomically connected, cell, contaminating in corruption of endogenous tau in the recipient cell through a seeding mechanism of templated misfolding. These mechanisms are very similar to those of other proteinopathies and to ideas about how prion pathologies spread through the brain. Nonetheless, the specific mechanisms underlying each of these steps remains uncertain and is a fertile ground for new experimental approaches potentially requiring new experimental models. We review, here, the state of the art of the research on tau prion-like propagation and we highlight some key challenges to understanding the detailed mechanisms of cell to cell propagation.

Entities:  

Keywords:  Alzheimer; Extracellular vesicles; Prion-like; Propagation; Secretion; Strains; Tau; Tauopathies; Uptake

Mesh:

Substances:

Year:  2019        PMID: 32096046     DOI: 10.1007/978-981-32-9358-8_23

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  15 in total

1.  Optimizing Epitope Conformational Ensembles Using α-Synuclein Cyclic Peptide "Glycindel" Scaffolds: A Customized Immunogen Method for Generating Oligomer-Selective Antibodies for Parkinson's Disease.

Authors:  Shawn C C Hsueh; Adekunle Aina; Andrei Yu Roman; Neil R Cashman; Xubiao Peng; Steven S Plotkin
Journal:  ACS Chem Neurosci       Date:  2022-07-15       Impact factor: 5.780

2.  Molecular crowding and RNA synergize to promote phase separation, microtubule interaction, and seeding of Tau condensates.

Authors:  Janine Hochmair; Christian Exner; Maximilian Franck; Alvaro Dominguez-Baquero; Lisa Diez; Hévila Brognaro; Matthew L Kraushar; Thorsten Mielke; Helena Radbruch; Senthilvelrajan Kaniyappan; Sven Falke; Eckhard Mandelkow; Christian Betzel; Susanne Wegmann
Journal:  EMBO J       Date:  2022-03-17       Impact factor: 14.012

Review 3.  Neuropathology of Alzheimer's Disease.

Authors:  Jorge A Trejo-Lopez; Anthony T Yachnis; Stefan Prokop
Journal:  Neurotherapeutics       Date:  2021-11-02       Impact factor: 6.088

Review 4.  Neuropathological assessment of the Alzheimer spectrum.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2020-08-01       Impact factor: 3.575

5.  Tau molecular diversity contributes to clinical heterogeneity in Alzheimer's disease.

Authors:  Simon Dujardin; Caitlin Commins; Aurelien Lathuiliere; Pieter Beerepoot; Analiese R Fernandes; Tarun V Kamath; Mark B De Los Santos; Naomi Klickstein; Diana L Corjuc; Bianca T Corjuc; Patrick M Dooley; Arthur Viode; Derek H Oakley; Benjamin D Moore; Kristina Mullin; Dinorah Jean-Gilles; Ryan Clark; Kevin Atchison; Renee Moore; Lori B Chibnik; Rudolph E Tanzi; Matthew P Frosch; Alberto Serrano-Pozo; Fiona Elwood; Judith A Steen; Matthew E Kennedy; Bradley T Hyman
Journal:  Nat Med       Date:  2020-06-22       Impact factor: 53.440

Review 6.  Towards an improved early diagnosis of neurodegenerative diseases: the emerging role of in vitro conversion assays for protein amyloids.

Authors:  Niccolò Candelise; Simone Baiardi; Alessia Franceschini; Marcello Rossi; Piero Parchi
Journal:  Acta Neuropathol Commun       Date:  2020-07-25       Impact factor: 7.801

Review 7.  Tau and Alpha Synuclein Synergistic Effect in Neurodegenerative Diseases: When the Periphery Is the Core.

Authors:  Elena Vacchi; Alain Kaelin-Lang; Giorgia Melli
Journal:  Int J Mol Sci       Date:  2020-07-16       Impact factor: 5.923

8.  The molecular tweezer CLR01 improves behavioral deficits and reduces tau pathology in P301S-tau transgenic mice.

Authors:  Jing Di; Ibrar Siddique; Zizheng Li; Ghattas Malki; Simon Hornung; Suman Dutta; Ian Hurst; Ella Ishaaya; Austin Wang; Sally Tu; Ani Boghos; Ida Ericsson; Frank-Gerrit Klärner; Thomas Schrader; Gal Bitan
Journal:  Alzheimers Res Ther       Date:  2021-01-04       Impact factor: 8.823

9.  Laterality and region-specific tau phosphorylation correlate with PTSD-related behavioral traits in rats exposed to repetitive low-level blast.

Authors:  Georgina Perez Garcia; Rita De Gasperi; Miguel A Gama Sosa; Gissel M Perez; Alena Otero-Pagan; Dylan Pryor; Rania Abutarboush; Usmah Kawoos; Patrick R Hof; Dara L Dickstein; David G Cook; Sam Gandy; Stephen T Ahlers; Gregory A Elder
Journal:  Acta Neuropathol Commun       Date:  2021-03-01       Impact factor: 7.801

10.  Small-molecule modulation of the p75 neurotrophin receptor inhibits a wide range of tau molecular pathologies and their sequelae in P301S tauopathy mice.

Authors:  Tao Yang; Harry Liu; Kevin C Tran; Albert Leng; Stephen M Massa; Frank M Longo
Journal:  Acta Neuropathol Commun       Date:  2020-09-05       Impact factor: 7.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.